Literature DB >> 8246297

Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin.

J E Dennis1, A I Caplan.   

Abstract

Cultured marrow-derived rat (Rattus norvegicus) mesenchymal cells can differentiate into osteoblasts when combined with an appropriate delivery vehicle and implanted in vivo. Porous ceramics have been successfully utilized for this purpose; however, the cellular interactions with these ceramics have not been delineated, and the optimal conditions for cell loading have not been determined. We have investigated the effects of ceramic pre-treatment with fibronectin and laminin on culture-expanded marrow mesenchymal cells. Scanning electron microscopic imaging was used for assessment of the interaction of these osteogenic cells with treated and untreated ceramic surfaces. The capability of pre-treated and untreated ceramics to retain an inoculum of these cells was determined by quantitation of [3H]thymidine-labeled cells added to ceramics and implanted subcutaneously into syngeneic rat hosts. Finally, the rate of bone formation in ceramic-cell composites, at harvest times ranging from 1 to 5+ wk, was determined histologically. Scanning electron microscopic images indicate that ceramics pre-treated with either laminin or fibronectin provide a surface on which marrow mesenchymal cells spread. Fibronectin and laminin increase cell retention within coated ceramics compared with uncoated controls. Furthermore, morphological evidence of osteogenesis is observed earlier in coated than in untreated ceramics. These observations indicate that cell attachment proteins, such as fibronectin, may augment bone formation in cell-ceramic composites by promoting the attachment and retention of osteoprogenitor cells within ceramic pores.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8246297

Source DB:  PubMed          Journal:  J Oral Implantol        ISSN: 0160-6972            Impact factor:   1.779


  10 in total

1.  MSC frequency correlates with blood vessel density in equine adipose tissue.

Authors:  Lindolfo da Silva Meirelles; Theodore T Sand; Robert J Harman; Donald P Lennon; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2009-02       Impact factor: 3.845

2.  Glucocorticoid receptor antagonist and siRNA prevent senescence of human bone marrow mesenchymal stromal cells in vitro.

Authors:  Na Wei; Yang Yu; Vijaya Joshi; Thomas Schmidt; Fang Qian; Aliasger K Salem; Clark Stanford; Liu Hong
Journal:  Cell Tissue Res       Date:  2013-08-21       Impact factor: 5.249

3.  Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases.

Authors:  Maneesh Dave; Paola Menghini; Keiki Sugi; Rodrigo A Somoza; Zhenghong Lee; Mukesh Jain; Arnold Caplan; Fabio Cominelli
Journal:  J Vis Exp       Date:  2017-09-01       Impact factor: 1.355

4.  The effect of devitalized trabecular bone on the formation of osteochondral tissue-engineered constructs.

Authors:  Eric G Lima; Pen-Hsiu Grace Chao; Gerard A Ateshian; B Sonny Bal; James L Cook; Gordana Vunjak-Novakovic; Clark T Hung
Journal:  Biomaterials       Date:  2008-08-20       Impact factor: 12.479

5.  Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor.

Authors:  Donald Lennon; Luis A Solchaga; Rodrigo A Somoza; Mark D Schluchter; Seunghee Margevicius; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2018-08-22       Impact factor: 3.845

6.  The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells.

Authors:  Donald P Lennon; Mark D Schluchter; Arnold I Caplan
Journal:  Stem Cells Transl Med       Date:  2012-04-02       Impact factor: 6.940

7.  Defining human mesenchymal stem cell efficacy in vivo.

Authors:  Tracey L Bonfield; Mary T Nolan Koloze; Donald P Lennon; Arnold I Caplan
Journal:  J Inflamm (Lond)       Date:  2010-10-25       Impact factor: 4.981

8.  Osteogenic Matrix Cell Sheets Facilitate Osteogenesis in Irradiated Rat Bone.

Authors:  Yoshinobu Uchihara; Manabu Akahane; Takamasa Shimizu; Tomoyuki Ueha; Yusuke Morita; Shintaro Nakasaki; Tomohiko Kura; Yasuaki Tohma; Akira Kido; Kenji Kawate; Yasuhito Tanaka
Journal:  Biomed Res Int       Date:  2015-05-12       Impact factor: 3.411

Review 9.  Mesenchymal stem cells in tissue repair.

Authors:  Amy M Dimarino; Arnold I Caplan; Tracey L Bonfield
Journal:  Front Immunol       Date:  2013-09-04       Impact factor: 7.561

Review 10.  Why are MSCs therapeutic? New data: new insight.

Authors:  A I Caplan
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.